Mkts

Ligand Pharmaceuticals Incorporated

NASDAQ: LGND
$286.85-0.09 (-0.03%)
As of Nov 20, 4:00 PM ET

Key statistics

Day range
282.36291.36
52-week range
175.89326.63
Today
Open285.21
Previous close286.85
Volume—
Valuation
Market cap5.74B
P/E ratio111.53×
EPS (TTM)2.29
Income & risk
Dividend / yield—
Beta1.30
Avg volume242.7K
Discussion

LGND News

Stories mentioning LGND from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue51,72259,666115,46147,62745,33342,81251,81241,531
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development2,1483,51121,0196,56750,0854,4255,6755,354
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)17,36813,84354,9318,444(36,216)(9,637)3,143(19,100)
Interest Income6,6556,3933,8741,6211,7711,9311,3472,757
Interest Expense
Other Expense(1,175)1,483(443.00)1,372(2,501)24,864(9,466)(33,523)
Pretax Income(24,259)56,780141,13711,223(50,180)(39,200)(6,339)(65,390)
Tax Provision(10,914)11,99623,8646,376(7,729)(8,112)833.00(13,479)
Net Income (Loss)(13,345)44,784117,2734,847(42,451)(31,088)(7,172)(51,911)
Earnings Per Share (Basic)(0.67)2.325.990.25(2.21)(1.70)(0.39)(2.88)
Earnings Per Share (Diluted)(0.67)2.215.680.24(2.21)(1.70)(0.39)(2.88)
Weighted Average Shares Outstanding (Basic)19,88319,33819,57819,32719,19118,29018,41918,028
Weighted Average Shares Outstanding (Diluted)19,88320,29420,62919,92619,19118,29018,41918,028

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About LGND

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is a stock listed on the Nasdaq Stock Market under the ticker symbol LGND. It last traded at $286.85 (Nov 20, 2026, 4:00 PM ET), down 0.0% on the day. That gives Ligand Pharmaceuticals a market capitalisation of $5.7B and a price-to-earnings ratio of 111.5.

Over the past 52 weeks LGND has traded between $175.89 and $326.63.

Revenue for the quarter ended Mar 31, 2026 was $51.7M; a net loss of $13.3M. Revenue was up 14.1% from $45.3M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$51.7M-$13.3M-25.8%
Dec 31, 2025$59.7M$44.8M75.1%
Sep 30, 2025$115.5M$117.3M101.6%
Jun 30, 2025$47.6M$4.8M10.2%

From Ligand Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…